Morgan Stanley Venus Concept Inc. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.18 - $0.38 $2,032 - $4,290	-11,292 Reduced 72.27%	4,332 $0
Q4 2022 Feb 14, 2023	BUY	$0.16 - $6.5 $995 - $40,443	6,222 Added 66.18%	15,624 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.31 - $7.41 $0 - $14	-2 Reduced 0.02%	9,402 $4,000
Q2 2022 Oct 27, 2022	SELL	$0.45 - $1.57 $438 - $1,530	-975 Reduced 9.39%	9,404 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.45 - $1.57 $438 - $1,530	-975 Reduced 9.39%	9,404 $4,000
Q1 2022 Oct 27, 2022	BUY	$1.29 - $1.85 $1,257 - $1,803	975 Added 10.37%	10,379 $14,000
Q1 2022 May 13, 2022	SELL	$1.29 - $1.85 $45,282 - $64,940	-35,103 Reduced 77.18%	10,379 $14,000
Q4 2021 Feb 14, 2022	SELL	$1.19 - $2.42 $297,808 - $605,626	-250,259 Reduced 84.62%	45,482 $77,000
Q3 2021 Nov 15, 2021	BUY	$1.79 - $3.27 $529,376 - $967,073	295,741 New	295,741 $742,000

Ticker VERO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 65,459,600
Market Cap $20.3M
Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.